Literature DB >> 15467195

Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.

Jungsook Cho1, Hyeong-Kyu Lee.   

Abstract

The present study evaluated the effect of wogonin, a flavonoid originated from the root of Scutellaria baicalensis GEORGI, on focal ischemic brain injury in rats. Focal brain ischemia was induced by the permanent occlusion of middle cerebral artery (pMCAO) for 24 h with a silicone rubber cylinder inserted through the right internal carotid artery. We found that wogonin, intraperitoneally administered at a dosage of 20 mg/kg at 30 min before and 4 h after the surgery, reduced the pMCAO-induced infarct areas in the cerebral cortex as well as in the striatum. The total volume of infarction was significantly reduced by the treatment with wogonin. In addition, wogonin was found to significantly improve the pMCAO-induced behavioral deficits at 24 h after the surgery. Taken together, these results demonstrate that wogonin inhibits ischemic brain injury and improves behavioral dysfunction caused by pMCAO. These findings, along with previous reports demonstrating the neuroprotective effects of wogonin, provide strong pharmacological basis for the use of wogonin or Scutellaria baicalensis in the treatment of stroke.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467195     DOI: 10.1248/bpb.27.1561

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  21 in total

Review 1.  Dietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins.

Authors:  Christopher C Leonardo; Sylvain Doré
Journal:  Nutr Neurosci       Date:  2011-09       Impact factor: 4.994

Review 2.  Scutellaria baicalensis in stroke management: nature's blessing in traditional Eastern medicine.

Authors:  Bhakta Prasad Gaire; Sang-Kwan Moon; Hocheol Kim
Journal:  Chin J Integr Med       Date:  2014-04-22       Impact factor: 1.978

Review 3.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

Review 4.  Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury.

Authors:  Peng-fei WU; Zui ZHANG; Fang WANG; Jian-guo CHEN
Journal:  Acta Pharmacol Sin       Date:  2010-12       Impact factor: 6.150

5.  Wogonin prevents rat dorsal root ganglion neurons death via inhibiting tunicamycin-induced ER stress in vitro.

Authors:  Shujuan Xu; Xin Zhao; Quanlai Zhao; Quan Zheng; Zhen Fang; Xiaoming Yang; Hong Wang; Ping Liu; Hongguang Xu
Journal:  Cell Mol Neurobiol       Date:  2014-11-09       Impact factor: 5.046

6.  Wogonin protects rat dorsal root ganglion neurons against tunicamycin-induced ER stress through the PERK-eIF2α-ATF4 signaling pathway.

Authors:  Fangyi Chen; Rongbo Wu; Zhu Zhu; Wangping Yin; Min Xiong; Jianwei Sun; Miaozhong Ni; Guoping Cai; Xinchao Zhang
Journal:  J Mol Neurosci       Date:  2014-11-23       Impact factor: 3.444

7.  Neuroprotective effect of baicalin in a rat model of permanent focal cerebral ischemia.

Authors:  Xian-Kun Tu; Wei-Zhong Yang; Song-Sheng Shi; Chun-Hua Wang; Chun-Mei Chen
Journal:  Neurochem Res       Date:  2009-03-18       Impact factor: 3.996

Review 8.  Baicalein, Baicalin, and Wogonin: Protective Effects against Ischemia-Induced Neurodegeneration in the Brain and Retina.

Authors:  Li Pan; Kin-Sang Cho; Irvin Yi; Chi-Ho To; Dong Feng Chen; Chi-Wai Do
Journal:  Oxid Med Cell Longev       Date:  2021-06-29       Impact factor: 7.310

9.  Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.

Authors:  Zhiqun Tan
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-14

10.  Erratum: Neural protection by naturopathic compounds-an example of tetramethylpyrazine from retina to brain.

Authors:  Zhiqun Tan
Journal:  J Ocul Biol Dis Infor       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.